A top-five shareholder in struggling Covid-19 vaccine maker Novavax is calling for an “urgent shake-up” of the board and an overhaul of its sales strategy, as the stock is down 99 per cent from its pandemic peak.
陷入困境的新冠疫苗制造商Novavax的五大股東之一呼吁對董事會進行“緊急改組”，并徹底改革其銷售戰略。該公司股價已從疫情高峰期下跌99%。
您已閱讀5%（283字），剩余95%（5621字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。